FDA Denies Approval for Neffy Epinephrine Nasal Spray: Effective Solution for Severe Allergic Reactions Remains Unavailable
The Food and Drug Administration decided not to approve Neffy, an epinephrine nasal spray developed by ARS Pharmaceuticals, which means that the first needle-free option for treating severe allergic reactions won’t be available to the American market until more trial data is gathered. ARS had anticipated the FDA’s approval for Neffy’s use in adults and …
